Aneurysm Therapy
A brain aneurysm is a weak, bulging spot on the wall of an artery. Our unique portfolio for ruptured and unruptured aneurysms is backed by numerous clinical studies and independent research for great performance and versatility.
Ischemic Stroke and Carotid Artery Disease
A stroke is a permanent injury to the brain caused by a blockage of blood flow that deprives brain tissue of oxygen and nutrients. This diverse portfolio includes carotid stents, aspiration catheters, and mechanical thrombectomy products.
Neurovascular Malformations
Malformations are an abnormal tangle of blood vessels that cause arteries to shunt directly into veins, the blood flow never slows down enough to provide oxygen and nutrients. We took a novel approach by designing a ready-to-use liquid embolic device for malformations.
Products
Our cutting-edge products lead the way in neuroendovascular therapies.
Featured Products
Aneurysm Therapy
Ischemic Stroke and Carotid Artery Disease
Neurovascular Malformations
Access Product Solutions
Latest Videos
MicroVention's 25th Anniversary History of Innovations
Latest News
Costa Rica's President Rodrigo Chaves Robles Recognizes MicroVention's Achievements with its Door To The Future Program and Signs National Employment Program Decree at MicroVention
Aliso Viejo, California andAlajuela, Costa Rica, April 11, 2023 – MicroVention, Inc., a global neurovascular company and wholly owned subsidiary of Terumo Corporation, today hosted the Republic of Costa Rica’s President Rodrigo Chaves Robles and other government officials and dignitaries at its Costa Rica facility in Alajuela.
MicroVention Celebrates 25 Years in Neuroendovascular Technologies that Improve Patient Lives
MicroVention, Inc., a global neurovascular company and a wholly owned subsidiary of Terumo Corporation, celebrates its 25-year anniversary on September 29, 2022. Founded in 1997 by a handful of Associates in Southern California, MicroVention is now a worldwide community with over 3,000 Associates and distributors worldwide, with offices across the United States, Europe, Asia, and Costa Rica.
MicroVention Earns 2022 Great Place to Work Certification™
The prestigious award is based entirely on what current employees say about their experience working at MicroVention. This year, 80% of employees said it’s a great place to work – 21 points higher than the average U.S. company.
MicroVention Announces First Patient Enrolled in the STRAIT Study with the New BOBBY™ Balloon Guide Catheter
MicroVention, Inc., a wholly owned subsidiary of Terumo Corporation, announced the successful completion of its first enrollment in a multi-center, prospective EU observational study called STRAIT, to evaluate the Safety and Performance of the BOBBY Balloon Guide Catheter for Endovascular Treatment of Acute Ischemic Stroke.
